Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: smh who wrote (3772)	5/12/2001 11:44:13 AM
From: Michael Young	Read Replies (1) \| Respond to of 52153

<<The biotech mafia has run biotech for years; heck, the genomics frenzy of 2000 was one of the few times it didn't run things. The mafia is comprised of smart, highly educated fund managers who do large amounts of analysis and use a phalanx of docs to figure out which clinical trials have a prayer of success. In the process, they also suss out which companies should be shorted. Makes 'em a pretty fearsome bunch. (Tell me Merlin Biomedical is short a stock I own, and I'll then look at it with a jaundiced eye. The same is true for a dozen other firms you might name.)>> I've noticed the same. A lot of the biotechs most touted on internet message boards are the ones these guys are heavily short. CLPA probably a prime example, but there are plenty of others. MIKE